Repeat of .23 cent run? Reasons for Scie success
The last run up to .23 cents was, in my opinion, due mostly to a constant stream of PRs. It died down, among other things, because distribution wasn't able to keep up with demand and investors became bored.
SCIE has an incredible amount of energy building right now. Check it out:
This year alone, we've had SEVEN PR's in 5 months. NONE contained fluff. I know of countless stocks that haven't had seven PR's in three years.
The 10Q should be coming out tomorrow.
The last company to have a licensing agreement with Duke sold to Toshiba for over $10 a share. SCIE now has a licensing agreement with Duke.
Oncoscope acquisition isn't a long forgotten memory. Something big is in the works.
SCIE is probably working on a second device as we speak for Barrett's esophagus which uses Duke/Oncoscope tech. When we get a PR for this, its going to get cray-cray in here.
Medtech2017 in January. SCIE is on the FRONT webpage under JOHNSON & JOHNSON. Free publicity doesn't get any better than that!
SCIE is building distribution in China as we speak.
Wavstat4 is in the middle east. Possible sales from Saudi Arabia this year.
Europe sales very possible this year.
England is slowly coming on board. Probably hear about them in 2017 (could be sooner).
Tons of free publicity. Twitter accounts are picking up Spectrascience's PRs.
Barrett's esophagus website for cancer treatment shows SCIE's PR for Duke's agreement with SCIE.
The 10K showed $6600 in sales. $825 per box of forceps x 8 boxes = $6600. Coincidence? I don't think so. Someone bought them.
Dr. Neumann, ridiculously well known in the endoscopy world, has mentioned the success of the WavSTAT numerous times. Among other things, he also wrote about PENTAX's iSCAN found on the same PETAX website where the Wavstat is displayed.
JagWorldwide showed a picture last Friday of the wavstat in SPAIN. Hospitals aren't going to waste time, money, and resources training doctors and nurses if they aren't planning on buying it!
Standard biopsies are archaic! We are an internet connected, technologically advanced society. Optical biopsies are not only the 'future' of biopsies, they are coming online right now.
SCIE is working with PENTAX! Owned by HOYA!
Wavstat is on the PENTAX website.
Wavstat works with bladder lesions.
SCIE is at the forefront in this field. They own many patents which wont expire until 2020+. CEO Oliver probably wants to sell SCIE well before 2020. He's a successful business man and probably wants to retire with a bang.
Wavstat showing up on UK's NHS website numerous times.
MORDIS trial in effect; recruiting live human beings.
SCIE is extremely transparent with investors.
Chart showing an obvious turn around in trend. Higher lows since November 2015.
The wavstat is a real product, used on real humans, showing real results. I don't know about anyone else, but this list shows me the risk/reward ratio is worth my investment.
